HomeNewsInterviewInterview | Staying connected to consumers and community is the mantra to survive the COVID-19 crisis, says Senco Gold’s Suvankar Sen

Interview | Staying connected to consumers and community is the mantra to survive the COVID-19 crisis, says Senco Gold’s Suvankar Sen

Although gold prices will remain volatile in the short term, in two years' time it will witness an upward trend, predicts the jewelry veteran

Mumbai / April 23, 2021 / 07:41 IST
Story continues below Advertisement

What could be the motto of a company with a legacy of over five decades during the difficult times we are treading currently?

"Senco Gold and Diamonds' mantra to survive the COVID-19 crisis is staying connected to its consumers and community", Suvankar Sen, CEO and Executive Director said in an interaction with Moneycontrol.

Story continues below Advertisement

The Kolkata-headquartered jewellery behemoth has adopted a two-pronged strategy to invest in both offline and online infrastructure.

“Going against the grain, we opened one of our biggest stores nationally - a new 7000 sq. ft store at Bowbazar area which is popular for being the jewellery hub of Kolkata. Jewellery shopping through video calling facility, use of technology with a revamped e-commerce channel for smoother customer experience, introduction of e-catalogues and virtual trial rooms were some of the innovations.”

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show